C1 Esterase Inhibitor Concentrate (C1-INH) for the Treatment of Acute Attacks of Hereditary Angioedema: Interim Results of an Ongoing, Prospective, Open Label Study in North America after 640 attacks (I.M.P.A.C.T.2)

C1 Esterase Inhibitor Concentrate (C1-INH) for the Treatment of Acute Attacks of Hereditary Angioedema: Interim Results of an Ongoing, Prospective, Open Label Study in North America after 640 attacks (I.M.P.A.C.T.2)

C1-Inhibitor replacement therapy is regarded as the gold standard for acute attacks of hereditary angioedema (HAE) especially for laryngeal, facial and abdominal attacks.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2009-02, Vol.123 (2), p.S99-S99
Hauptverfasser: Levy, R.L, Wasserman, R.L, Bewtra, A.K, Hurewitz, D.H, Moy, J.N, Yang, W.H, Schneider, L.C, Packer, F.R, Bahna, S.L, Jacobson, K.W, Offenberger, J, Eidelman, F, Janss, G, Kiessling, P.C, Peters, C.P, Craig, T.C
Format: Artikel
Sprache:eng
Schlagworte:
Abdomen
Allergy and Immunology
Drug therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:C1-Inhibitor replacement therapy is regarded as the gold standard for acute attacks of hereditary angioedema (HAE) especially for laryngeal, facial and abdominal attacks.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2008.12.358